You are not authorized to access this page.

815 Results

People

  1. Offit
    Offit
  2. Breitbart
    Breitbart
  3. Robson
    Robson
  4. Mulhall
    Mulhall
  5. Ostroff
    Ostroff
  6. Sepkowitz
    Sepkowitz
  7. Halpern
    Halpern
  8. Nelson
    Nelson
  9. Sklar
    Sklar
  10. Berger
    Berger

Groups

  1. Department of Medicine (277)
  2. Population Sciences Research Program (234)
  3. Survivorship Research (212)
  4. Surgery (189)
  5. Solid Tumor Oncology Division (125)
  6. Epidemiology and Biostatistics (122)
  7. Division of Subspecialty Medicine (119)
  8. Psychiatry and Behavioral Sciences, Department of (106)
  9. GSK Faculty (92)
  10. Department of Pathology and Laboratory Medicine (83)
  1. "prevalence"
Formats
  1. Journal Article (718)
  2. Review (49)
  3. Editorial (18)
  4. Book Section (8)
  5. Research Letter (8)
  6. Correspondence (7)
  7. Guidelines (3)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (277)
  2. Population Sciences Research Program (234)
  3. Survivorship Research (212)
  4. Surgery (189)
  5. Solid Tumor Oncology Division (125)
  6. Epidemiology and Biostatistics (122)

More Groups

People
  1. Kenneth Offit (28)
  2. William Breitbart (26)
  3. Mark Robson (24)
  4. John Mulhall (19)
  5. Kent Sepkowitz (16)
  6. Jamie Ostroff (15)

More People

Years
  1. 2025 (34)
  2. 2024 (91)
  3. 2023 (49)
  4. 2022 (37)
  5. 2021 (19)
  6. 2020 (42)

More Years

Publications
  1. Cancer (38)
  2. Journal of Clinical Oncology (17)
  3. Journal of Sexual Medicine (15)
  4. JNCI: Journal of the National Cancer Institute (13)
  5. Journal of the National Comprehensive Cancer Network (12)
  6. Gynecologic Oncology (11)

More Publications

Publishers
  1. Elsevier Inc. (100)
  2. Wiley Blackwell (66)
  3. Elsevier Science, Inc. (65)
  4. Springer (52)
  5. Oxford University Press (47)
  6. Lippincott Williams & Wilkins (38)

More Publishers

Results (815)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DNA damage response alterations predict for neoadjuvant chemotherapy sensitivity in muscle-invasive bladder cancer: A correlative analysis of the SWOG S1314 trial
    Journal Article

    Iyer, G.; Tangen, C. M.; Sarfaty, M.; Regazzi, A. M.; Lee, I. L.; Fong, M.; Choi, W.; Dinney, C. P. N.; Flaig, T. W.; Thompson, I. M. Jr; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Global unmet psychosocial needs in cancer care: Health policy
    Review

    Bergerot, C.; Jacobsen, P. B.; Rosa, W. E.; Lam, W. W. T.; Dunn, J.; Fernández-González, L.; Mehnert-Theuerkauf, A.; Veeraiah, S.; Li, M.
    eClinicalMedicine (2024)

    Fulltext@MSK | Save
  • Prevalence and pathologic characterization of mouse kidney parvovirus in sentinel CD1 mice
    Journal Article

    Ge, Z.; Feng, Y.; Parry, N. M.; Annamalai, D.; Carrasco, S. E.; Guo, M.; Muthupalani, S.; Erdman, S. E.; Fox, J. G.
    Comparative Medicine (2024)

    Fulltext@MSK | Save
  • Clinical utility of a digital dermoscopy image-based artificial intelligence device in the diagnosis and management of skin cancer by dermatologists
    Journal Article

    Witkowski, A. M.; Burshtein, J.; Christopher, M.; Cockerell, C.; Correa, L.; Cotter, D.; Ellis, D. L.; Farberg, A. S.; Grant-Kels, J. M.; Greiling, T. M.; more...
    Cancers (2024)

    Fulltext@MSK | Save
  • Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
    Journal Article

    Shimony, S.; Raman, H. S.; Flamand, Y.; Keating, J.; Paolino, J. D.; Valtis, Y. K.; Place, A. E.; Silverman, L. B.; Sallan, S. E.; Vrooman, L. M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • TP53 Y220C mutations in patients with myeloid malignancies
    Research Letter

    Gener-Ricos, G.; Bewersdorf, J. P.; Loghavi, S.; Bataller, A.; Goldberg, A. D.; Sasaki, K.; Famulare, C.; Takahashi, K.; Issa, G. C.; Borthakur, G.; more...
    Leukemia and Lymphoma (2024)

    Fulltext@MSK | Save
  • Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: Results of the phase 3 TiNivo-2 study
    Journal Article

    Choueiri, T. K.; Albiges, L.; Barthélémy, P.; Iacovelli, R.; Emambux, S.; Molina-Cerrillo, J.; Garmezy, B.; Barata, P.; Basu, A.; Bourlon, M. T.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Equivocal bone lesions on PSMA PET/CT: Systematic review and meta-analysis on their prevalence and malignancy rate
    Review

    Woo, S.; Freedman, D.; Becker, A. S.; Leithner, D.; Mayerhoefer, M. E.; Friedman, K. P.; Arita, Y.; Han, S.; Burger, I. A.; Taneja, S. S.; more...
    Clinical and Translational Imaging (2024)

    Fulltext@MSK | Save
  • ASO Author Reflections: Young adults and racial minorities may be at high risk for financial toxicity after breast cancer treatment
    Editorial

    Myers, S. P.; Aviki, E.; Sevilimedu, V.; Thom, B.; Gemignani, M. L.
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • LGBTQIA+ inclusion in the global health policy agenda: A critical discourse analysis of the Lancet Commission report archive
    Journal Article

    Rosa, W. E.; Goitiandia, S. W.; Braybrook, D.; Metheny, N.; Roberts, K. E.; McDarby, M.; Behrens, M.; Berkman, C.; Stein, G. L.; Adedimeji, A.; more...
    PLoS ONE (2024)

    Fulltext@MSK | Save